Physicians across several specialties are aware of guidelines recommending avoidance of TNF‐α inhibitors (TNF‐i) when treating patients for immune‐mediated inflammatory diseases (IMIDs) who also suffer from advanced heart failure (HF). The gene discussed is TNF; the disease is hydrops fetalis.